723 related articles for article (PubMed ID: 16093455)
1. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS.
Veldink JH; Kalmijn S; Van der Hout AH; Lemmink HH; Groeneveld GJ; Lummen C; Scheffer H; Wokke JH; Van den Berg LH
Neurology; 2005 Sep; 65(6):820-5. PubMed ID: 16093455
[TBL] [Abstract][Full Text] [Related]
2. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS.
Corcia P; Camu W; Halimi JM; Vourc'h P; Antar C; Vedrine S; Giraudeau B; de Toffol B; Andres CR;
Neurology; 2006 Oct; 67(7):1147-50. PubMed ID: 16931506
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama's disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients.
Gamez J; Also E; Alias L; Corbera-Bellalta M; Barceló MJ; Centeno M; Raguer N; Gratacós M; Baiget M; Tizzano EF
Clin Neurol Neurosurg; 2007 Dec; 109(10):844-8. PubMed ID: 17850955
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test.
Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM
Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310
[TBL] [Abstract][Full Text] [Related]
5. Molecular and functional analysis of intragenic SMN1 mutations in patients with spinal muscular atrophy.
Sun Y; Grimmler M; Schwarzer V; Schoenen F; Fischer U; Wirth B
Hum Mutat; 2005 Jan; 25(1):64-71. PubMed ID: 15580564
[TBL] [Abstract][Full Text] [Related]
6. Spinal muscular atrophy diagnostics.
Prior TW
J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1.
Ogino S; Gao S; Leonard DG; Paessler M; Wilson RB
Eur J Hum Genet; 2003 Mar; 11(3):275-7. PubMed ID: 12673282
[TBL] [Abstract][Full Text] [Related]
8. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy.
Zapletalová E; Hedvicáková P; Kozák L; Vondrácek P; Gaillyová R; Maríková T; Kalina Z; Jüttnerová V; Fajkus J; Fajkusová L
Neuromuscul Disord; 2007 Jun; 17(6):476-81. PubMed ID: 17475491
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
[TBL] [Abstract][Full Text] [Related]
10. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.
Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA
Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367
[TBL] [Abstract][Full Text] [Related]
11. Genotype determination at the survival motor neuron locus in a normal population and SMA carriers using competitive PCR and primer extension.
Gérard B; Ginet N; Matthijs G; Evrard P; Baumann C; Da Silva F; Gérard-Blanluet M; Mayer M; Grandchamp B; Elion J
Hum Mutat; 2000 Sep; 16(3):253-63. PubMed ID: 10980532
[TBL] [Abstract][Full Text] [Related]
12. Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy.
Arkblad EL; Darin N; Berg K; Kimber E; Brandberg G; Lindberg C; Holmberg E; Tulinius M; Nordling M
Neuromuscul Disord; 2006 Dec; 16(12):830-8. PubMed ID: 17049859
[TBL] [Abstract][Full Text] [Related]
13. Determination of SMN1 and SMN2 copy number using TaqMan technology.
Anhuf D; Eggermann T; Rudnik-Schöneborn S; Zerres K
Hum Mutat; 2003 Jul; 22(1):74-8. PubMed ID: 12815596
[TBL] [Abstract][Full Text] [Related]
14. Hydroxyurea enhances SMN2 gene expression in spinal muscular atrophy cells.
Grzeschik SM; Ganta M; Prior TW; Heavlin WD; Wang CH
Ann Neurol; 2005 Aug; 58(2):194-202. PubMed ID: 16049920
[TBL] [Abstract][Full Text] [Related]
15. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.
Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF
Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254
[TBL] [Abstract][Full Text] [Related]
16. Genetic study of SMA patients without homozygous SMN1 deletions: identification of compound heterozygotes and characterisation of novel intragenic SMN1 mutations.
Martín Y; Valero A; del Castillo E; Pascual SI; Hernández-Chico C
Hum Genet; 2002 Mar; 110(3):257-63. PubMed ID: 11935338
[TBL] [Abstract][Full Text] [Related]
17. Transmission ratio distortion in the spinal muscular atrophy locus: data from 314 prenatal tests.
Botta A; Tacconelli A; Bagni I; Giardina E; Bonifazi E; Pietropolli A; Clementi M; Novelli G
Neurology; 2005 Nov; 65(10):1631-5. PubMed ID: 16301493
[TBL] [Abstract][Full Text] [Related]
18. A sensitive assay for measuring SMN mRNA levels in peripheral blood and in muscle samples of patients affected with spinal muscular atrophy.
Vezain M; Saugier-Veber P; Melki J; Toutain A; Bieth E; Husson M; Pedespan JM; Viollet L; Pénisson-Besnier I; Fehrenbach S; Bou J; Frébourg T; Tosi M
Eur J Hum Genet; 2007 Oct; 15(10):1054-62. PubMed ID: 17609673
[TBL] [Abstract][Full Text] [Related]
19. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
Wirth B
Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
[TBL] [Abstract][Full Text] [Related]
20. The importance of the SMN genes in the genetics of sporadic ALS.
Corcia P; Camu W; Praline J; Gordon PH; Vourch P; Andres C
Amyotroph Lateral Scler; 2009; 10(5-6):436-40. PubMed ID: 19922137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
